Forall biomedical Co. Ltd., explores multi-faceted cancer treatment cooperation with Taiwan XX Hospital - 福眾生醫

Forall biomedical Co. Ltd., explores multi-faceted cancer treatment cooperation with Taiwan XX Hospital

Cancer has become the leading cause of death for Chinese people, with a mortality rate of 75 to 80%, which can be said to be the biggest threat to Chinese people’s health. The main reasons for the particularly low survival rate are the following:

  1. Most cancers are diagnosed at an advanced stage.
  2. The patient’s willingness to cooperate is not high.
  3. Common cancers in Taiwan are prone to drug resistance.
  4. The medical standards for cancer treatment are uneven.
  5. Lack of full-time oncologists.

Therefore, Fuzhongsheng Medical will establish a clinical research cooperation organization in XX, which is the most urgent task to reduce the mortality rate of cancer. This will be an inter-hospital clinical trial cooperation model for the same cancer treatment method, in order to effectively use patient resources and ensure the safety and ethics of clinical research plans, and establish a rigorous review system for therapy and academic research, which will be effective Integration of domestic cancer